Published in Oncologist on October 03, 2011
Trends in utilization and outcomes of autologous transplantation as early therapy for multiple myeloma. Biol Blood Marrow Transplant (2013) 1.88
Cost-Effectiveness of Autologous Hematopoietic Stem Cell Transplantation for Elderly Patients with Multiple Myeloma using the Surveillance, Epidemiology, and End Results-Medicare Database. Biol Blood Marrow Transplant (2015) 1.42
Smoldering multiple myeloma requiring treatment: time for a new definition? Blood (2013) 1.09
Association of response endpoints with survival outcomes in multiple myeloma. Leukemia (2013) 1.08
European perspective on multiple myeloma treatment strategies: update following recent congresses. Oncologist (2012) 0.98
Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone. Haematologica (2015) 0.96
Multiple myeloma in the older adult: better prospects, more challenges. J Clin Oncol (2014) 0.95
Trends in autologous hematopoietic cell transplantation for multiple myeloma in Europe: increased use and improved outcomes in elderly patients in recent years. Bone Marrow Transplant (2014) 0.93
Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma. Haematologica (2015) 0.89
Multiple myeloma in the very old: an IASIA conference report. J Natl Cancer Inst (2014) 0.83
Large registry analysis to accurately define second malignancy rates and risks in a well-characterized cohort of 744 consecutive multiple myeloma patients followed-up for 25 years. Haematologica (2015) 0.82
Early relapse following initial therapy for multiple myeloma predicts poor outcomes in the era of novel agents. Leukemia (2016) 0.81
Multiple myeloma and kidney disease. ScientificWorldJournal (2013) 0.80
Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma. Blood (2016) 0.80
High expression of endoplasmic reticulum chaperone grp94 is a novel molecular hallmark of malignant plasma cells in multiple myeloma. J Hematol Oncol (2015) 0.80
New Treatment Approaches for Older Adults with Multiple Myeloma. J Geriatr Oncol (2012) 0.79
High-dose therapy and autologous stem cell transplant in older adults with multiple myeloma. Bone Marrow Transplant (2015) 0.78
The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study. BMC Cancer (2016) 0.77
Future distribution of multiple myeloma in the United States by sex, age, and race/ethnicity. Blood (2015) 0.77
Autologous stem cell transplantation in elderly patients with multiple myeloma: past, present, and future. Biomed Res Int (2014) 0.77
Analysis of renal impairment in MM-003, a phase III study of pomalidomide + low - dose dexamethasone versus high - dose dexamethasone in refractory or relapsed and refractory multiple myeloma. Haematologica (2016) 0.76
The outcomes of newly diagnosed elderly multiple myeloma patients treated at a single U.S. institution. Cancer Med (2016) 0.75
Risk of Second Primary Cancers in Multiple Myeloma Survivors in German and Swedish Cancer Registries. Sci Rep (2016) 0.75
VTD-melphalan is well tolerated and results in very high rates of stringent CR and MRD-negative status in multiple myeloma. Onco Targets Ther (2017) 0.75
Diagnostic and therapeutic approaches to multiple myeloma patients: 'Real-world' data from representative multicentre treatment surveys in Germany between 2008 and 2011. Oncol Lett (2016) 0.75
Flow cytometry quality requirements for monitoring of minimal disease in plasma cell myeloma. Cytometry B Clin Cytom (2015) 0.75
Long-term use of lenalidomide and low-dose dexamethasone in Chinese patients with relapsed/refractory multiple myeloma: MM-024 Extended Access Program. BMC Cancer (2016) 0.75
Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial. Blood Cancer J (2016) 0.75
Bendamustine in heavily pre-treated multiple myeloma patients: Results of a retrospective analysis from the Korean Multiple Myeloma Working Party. Blood Res (2016) 0.75
Holistic needs assessment in advanced, intensively treated multiple myeloma patients. Support Care Cancer (2014) 0.75
Cancer statistics, 2010. CA Cancer J Clin (2010) 103.28
Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma. N Engl J Med (2008) 13.06
The relative survival rate: a statistical methodology. Natl Cancer Inst Monogr (1961) 10.35
Lenalidomide plus dexamethasone for relapsed or refractory multiple myeloma. N Engl J Med (2007) 8.77
Recent major improvement in long-term survival of younger patients with multiple myeloma. Blood (2007) 4.08
An alternative approach to monitoring cancer patient survival. Cancer (1996) 3.59
United States life tables, 2000. Natl Vital Stat Rep (2002) 2.66
Efficacy of melphalan and prednisone plus thalidomide in patients older than 75 years with newly diagnosed multiple myeloma: IFM 01/01 trial. J Clin Oncol (2009) 2.49
The relative survival rate. Cancer (1995) 1.89
Phase III study of the value of thalidomide added to melphalan plus prednisone in elderly patients with newly diagnosed multiple myeloma: the HOVON 49 Study. J Clin Oncol (2010) 1.81
Up-to-date long-term survival curves of patients with cancer by period analysis. J Clin Oncol (2002) 1.44
Expected long-term survival of patients diagnosed with multiple myeloma in 2006-2010. Haematologica (2009) 1.39
Up-to-date and precise estimates of cancer patient survival: model-based period analysis. Am J Epidemiol (2006) 1.31
Estimation of confidence limits for the cumulative probability of survival in life table analysis. J Chronic Dis (1978) 1.28
Large-scale genotyping identifies 41 new loci associated with breast cancer risk. Nat Genet (2013) 8.24
Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data. Lancet Oncol (2007) 8.05
Meta-analysis of genome-wide association data identifies four new susceptibility loci for colorectal cancer. Nat Genet (2008) 6.97
Genome-wide association scan identifies a colorectal cancer susceptibility locus on 11q23 and replicates risk loci at 8q24 and 18q21. Nat Genet (2008) 6.75
C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med (2012) 6.39
Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array. Nat Genet (2013) 5.58
Tobacco-smoking-related differential DNA methylation: 27K discovery and replication. Am J Hum Genet (2011) 5.18
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
Recent major improvement in long-term survival of younger patients with multiple myeloma. Blood (2007) 4.08
Genome-wide association studies identify four ER negative-specific breast cancer risk loci. Nat Genet (2013) 3.81
Genome-wide association analysis identifies three new breast cancer susceptibility loci. Nat Genet (2012) 3.20
Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium. J Natl Cancer Inst (2010) 3.18
Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol (2009) 3.14
Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study. Nat Genet (2011) 3.07
Plasma concentrations of cystatin C in patients with coronary heart disease and risk for secondary cardiovascular events: more than simply a marker of glomerular filtration rate. Clin Chem (2004) 2.95
Identification of Genetic Susceptibility Loci for Colorectal Tumors in a Genome-Wide Meta-analysis. Gastroenterology (2012) 2.57
Trends in 5- and 10-year survival after diagnosis with childhood hematologic malignancies in the United States, 1990-2004. J Natl Cancer Inst (2008) 2.56
Smoking and all-cause mortality in older people: systematic review and meta-analysis. Arch Intern Med (2012) 2.42
Meta-analysis of new genome-wide association studies of colorectal cancer risk. Hum Genet (2011) 2.35
Vitamin D and cardiovascular disease: systematic review and meta-analysis of prospective studies. Prev Med (2010) 2.27
Atherogenic dyslipidaemia but not total- and high-molecular weight adiponectin are associated with the prognostic outcome in patients with coronary heart disease. Eur Heart J (2008) 2.26
Cost-effectiveness of colorectal cancer screening. Epidemiol Rev (2011) 2.24
Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. Am J Hum Genet (2013) 2.24
Secretory phospholipase A(2)-IIA and cardiovascular disease: a mendelian randomization study. J Am Coll Cardiol (2013) 2.18
Socioeconomic deprivation and cancer survival in Germany: an ecological analysis in 200 districts in Germany. Int J Cancer (2013) 2.18
Adiponectin, risk of coronary heart disease and correlations with cardiovascular risk markers. Eur Heart J (2005) 2.16
Blood markers for early detection of colorectal cancer: a systematic review. Cancer Epidemiol Biomarkers Prev (2007) 2.00
Changes in survival in head and neck cancers in the late 20th and early 21st century: a period analysis. Oncologist (2010) 1.94
The cancer survival gap between elderly and middle-aged patients in Europe is widening. Eur J Cancer (2008) 1.93
Older smokers' motivation and attempts to quit smoking: epidemiological insight into the question of lifestyle versus addiction. Dtsch Arztebl Int (2009) 1.92
Identification of a BRCA2-specific modifier locus at 6p24 related to breast cancer risk. PLoS Genet (2013) 1.88
Comparative evaluation of immunochemical fecal occult blood tests for colorectal adenoma detection. Ann Intern Med (2009) 1.84
19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res (2012) 1.81
Circulating adipocyte fatty acid-binding protein levels and cardiovascular morbidity and mortality in patients with coronary heart disease: a 10-year prospective study. Arterioscler Thromb Vasc Biol (2012) 1.80
Quality of life in patients with colorectal cancer 1 year after diagnosis compared with the general population: a population-based study. J Clin Oncol (2004) 1.80
Efficacy of a nationwide screening colonoscopy program for colorectal cancer. Gastroenterology (2012) 1.79
Fine-mapping identifies multiple prostate cancer risk loci at 5p15, one of which associates with TERT expression. Hum Mol Genet (2013) 1.78
Cross-sectional and longitudinal changes in DNA methylation with age: an epigenome-wide analysis revealing over 60 novel age-associated CpG sites. Hum Mol Genet (2013) 1.77
Cardiac troponin T measured by a high-sensitivity assay predicts recurrent cardiovascular events in stable coronary heart disease patients with 8-year follow-up. Clin Chem (2012) 1.76
Relationship of adiponectin with markers of systemic inflammation, atherogenic dyslipidemia, and heart failure in patients with coronary heart disease. Clin Chem (2006) 1.75
Epigenotyping in peripheral blood cell DNA and breast cancer risk: a proof of principle study. PLoS One (2008) 1.75
Helicobacter pylori infection and colorectal cancer risk: evidence from a large population-based case-control study in Germany. Am J Epidemiol (2012) 1.74
Comparison of N-terminal pro-B-natriuretic peptide, C-reactive protein, and creatinine clearance for prognosis in patients with known coronary heart disease. Arch Intern Med (2006) 1.73
Colorectal cancer mortality prevented by use and attributable to nonuse of colonoscopy. Gastrointest Endosc (2011) 1.72
The performance of methods for correcting measurement error in case-control studies. Epidemiology (2002) 1.71
Meta-analysis: serum vitamin D and breast cancer risk. Eur J Cancer (2010) 1.69
A systematic review of leukocyte telomere length and age in adults. Ageing Res Rev (2013) 1.67
Trends in long-term survival of patients with chronic lymphocytic leukemia from the 1980s to the early 21st century. Blood (2008) 1.65
Improvement in survival in younger patients with acute lymphoblastic leukemia from the 1980s to the early 21st century. Blood (2008) 1.65
Calcium, phosphate and the risk of cardiovascular events and all-cause mortality in a population with stable coronary heart disease. Heart (2012) 1.64
Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am J Clin Nutr (2013) 1.62
Flexible matching strategies to increase power and efficiency to detect and estimate gene-environment interactions in case-control studies. Am J Epidemiol (2002) 1.60
MicroRNA signatures: novel biomarker for colorectal cancer? Cancer Epidemiol Biomarkers Prev (2011) 1.60
Characterization of gene-environment interactions for colorectal cancer susceptibility loci. Cancer Res (2012) 1.58
Impact of national smoke-free legislation on home smoking bans: findings from the International Tobacco Control Policy Evaluation Project Europe Surveys. Tob Control (2012) 1.56
Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. Hum Mol Genet (2011) 1.56
Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors. PLoS Genet (2013) 1.56
Lipoprotein-associated phospholipase A2 predicts future cardiovascular events in patients with coronary heart disease independently of traditional risk factors, markers of inflammation, renal function, and hemodynamic stress. Arterioscler Thromb Vasc Biol (2006) 1.56
Epidemiology of Helicobacter pylori infection. Helicobacter (2004) 1.56
Assisted reproductive techniques and risk of exstrophy-epispadias complex: a German case-control study. J Urol (2012) 1.55
Cumulative impact of common genetic variants and other risk factors on colorectal cancer risk in 42,103 individuals. Gut (2012) 1.52
Recurrent abdominal pain in children: evidence from a population-based study that social and familial factors play a major role but not Helicobacter pylori infection. J Psychosom Res (2003) 1.51
Smoking, F2RL3 methylation, and prognosis in stable coronary heart disease. Eur Heart J (2012) 1.51
Recent major progress in long-term cancer patient survival disclosed by modeled period analysis. J Clin Oncol (2007) 1.49
A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum Mol Genet (2012) 1.47
High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality. Eur Heart J (2013) 1.46
Multiple tumours in survival estimates. Eur J Cancer (2009) 1.46
Long-term survival of patients diagnosed with non-Hodgkin lymphoma after a previous malignancy. Leuk Lymphoma (2009) 1.46
Physical activity, coronary heart disease, and inflammatory response. Arch Intern Med (2003) 1.44
Cancer survival in a southern African urban population. Int J Cancer (2004) 1.41
Provider delay among patients with breast cancer in Germany: a population-based study. J Clin Oncol (2003) 1.41
Expected long-term survival of patients diagnosed with multiple myeloma in 2006-2010. Haematologica (2009) 1.39
Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. Am J Hum Genet (2013) 1.39
Identification and evaluation of plasma microRNAs for early detection of colorectal cancer. PLoS One (2013) 1.39
Cancer survival differences between European countries and an urban population from the Philippines. Eur J Public Health (2010) 1.38
Acquisition of Helicobacter pylori infection in early childhood: independent contributions of infected mothers, fathers, and siblings. Am J Gastroenterol (2009) 1.37
F2RL3 methylation as a biomarker of current and lifetime smoking exposures. Environ Health Perspect (2013) 1.37
Kidney graft survival in Europe and the United States: strikingly different long-term outcomes. Transplantation (2013) 1.36
Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption. Cancer Epidemiol Biomarkers Prev (2006) 1.35
Epidemiology of chronic kidney disease: results from a population of older adults in Germany. Prev Med (2008) 1.34
Clinical relevance of conditional survival of cancer patients in europe: age-specific analyses of 13 cancers. J Clin Oncol (2010) 1.34
Helicobacter pylori infection and gastric cancer risk: evaluation of 15 H. pylori proteins determined by novel multiplex serology. Cancer Res (2009) 1.33
The diagnosis of a smoking-related disease is a prominent trigger for smoking cessation in a retrospective cohort study. J Clin Epidemiol (2005) 1.32
Information deficits in the summary of product characteristics preclude an optimal management of drug interactions: a comparison with evidence from the literature. Eur J Clin Pharmacol (2005) 1.32
Improvements in survival of adults diagnosed with acute myeloblastic leukemia in the early 21st century. Haematologica (2008) 1.31
Comprehensive smoke-free policies attract more support from smokers in Europe than partial policies. Eur J Public Health (2012) 1.29
Changes of cardiovascular risk factors and their implications in subsequent birth cohorts of older adults in Germany: a life course approach. Eur J Cardiovasc Prev Rehabil (2007) 1.28
Health-related quality of life during the 10 years after diagnosis of colorectal cancer: a population-based study. J Clin Oncol (2011) 1.28
Recent trends in long-term survival of patients with chronic myelocytic leukemia: disclosing the impact of advances in therapy on the population level. Haematologica (2008) 1.28
11q13 is a susceptibility locus for hormone receptor positive breast cancer. Hum Mutat (2012) 1.26
Association of diabetes and body mass index with levels of prostate-specific antigen: implications for correction of prostate-specific antigen cutoff values? Cancer Epidemiol Biomarkers Prev (2009) 1.25